These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 11741164
1. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy. Righetti E, Ballon G, Ometto L, Cattelan AM, Menin C, Zanchetta M, Chieco-Bianchi L, De Rossi A. AIDS; 2002 Jan 04; 16(1):63-73. PubMed ID: 11741164 [Abstract] [Full Text] [Related]
4. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. O'Sullivan CE, Peng R, Cole KS, Montelaro RC, Sturgeon T, Jenson HB, Ling PD. J Med Virol; 2002 Jul 04; 67(3):320-6. PubMed ID: 12116021 [Abstract] [Full Text] [Related]
5. Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus. Giron LB, Ramos da Silva S, Barbosa AN, Monteiro de Barros Almeida RA, Rosário de Souza Ld, Elgui de Oliveira D. J Med Virol; 2013 Dec 04; 85(12):2110-8. PubMed ID: 24014234 [Abstract] [Full Text] [Related]
8. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. Dehee A, Asselot C, Piolot T, Jacomet C, Rozenbaum W, Vidaud M, Garbarg-Chenon A, Nicolas JC. J Med Virol; 2001 Nov 04; 65(3):543-52. PubMed ID: 11596092 [Abstract] [Full Text] [Related]
10. Concurrent CMV and EBV DNAemia is significantly correlated with a delay in the response to HAART in treatment-naive HIV type 1-positive patients. Panagiotakis SH, Soufla G, Baritaki S, Sourvinos G, Passam A, Zagoreos I, Stavrianeas N, Spandidos DA. AIDS Res Hum Retroviruses; 2007 Jan 04; 23(1):10-8. PubMed ID: 17263627 [Abstract] [Full Text] [Related]
12. Evaluation of Epstein-Barr Virus Salivary Shedding in HIV/AIDS Patients and HAART Use: A Retrospective Cohort Study. Yan Y, Ren Y, Chen R, Hu J, Ji Y, Yang J, Shen J, Hu L, Pei H, Wang J, Qiu Y, Lu H, Huang L. Virol Sin; 2018 Jun 04; 33(3):227-233. PubMed ID: 29654554 [Abstract] [Full Text] [Related]
18. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells. Kostense S, Otto SA, Knol GJ, Manting EH, Nanlohy NM, Jansen C, Lange JM, van Oers MH, Miedema F, van Baarle D. Eur J Immunol; 2002 Apr 04; 32(4):1080-9. PubMed ID: 11920575 [Abstract] [Full Text] [Related]
19. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol]. Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R. G Ital Nefrol; 2003 Apr 04; 20(2):170-5. PubMed ID: 12746803 [Abstract] [Full Text] [Related]
20. Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda. Petrara MR, Penazzato M, Massavon W, Nabachwa S, Nannyonga M, Mazza A, Gianesin K, Del Bianco P, Lundin R, Sumpter C, Zanchetta M, Giaquinto C, De Rossi A. J Infect Dis; 2014 Aug 01; 210(3):392-9. PubMed ID: 24550442 [Abstract] [Full Text] [Related] Page: [Next] [New Search]